T1	Condition 13 22	emphysema
T2	Procedure 36 43	CT scan
R1	AND Arg1:T1 Arg2:T2	
T3	Procedure 65 72	CT scan
T4	Temporal 60 64	past
R2	Has_temporal Arg1:T3 Arg2:T4	
T6	Negation 76 89	not available
T7	Observation 50 72	report of past CT scan
R5	AND Arg1:T7 Arg2:T3	
T8	Procedure 117 124	CT scan
T9	Scope 50 89	report of past CT scan is not available
A1	Optional T9
R3	Has_negation Arg1:T3 Arg2:T6	
R4	AND Arg1:T9 Arg2:T8	
T5	Scope 50 156	report of past CT scan is not available at site documenting then a CT scan is to be performed at screening
T10	Temporal 144 156	at screening
R6	Has_temporal Arg1:T8 Arg2:T10	
T11	Reference_point 147 156	screening
R7	Subsumes Arg1:T2 Arg2:T5	
T12	Person 158 162	Male
T13	Person 166 172	female
T14	Value 182 199	at least 18 years
T15	Person 203 206	age
R8	Has_value Arg1:T15 Arg2:T14	
*	OR T13 T12
T16	Post-eligibility 209 254	Able and willing to sign an informed consent.
T17	Condition 279 335	congenital AAT deficiency of phenotype PiZZ (homozygote)
T18	Condition 345 386	rare phenotypes related to AAT deficiency
T19	Measurement 396 411	AAT serum level
T20	Value 412 426	≤ 11 micromole
R9	Has_value Arg1:T19 Arg2:T20	
*	OR T18 T17
T21	Procedure 451 478	IV AAT augmentation therapy
A2	Optional T21
T22	Context_Error 428 524	For patients receiving IV AAT augmentation therapy the serum AAT level threshold does not apply.
T23	Measurement 526 534	FEV1/SVC
T24	Value 535 558	<70% of predicted value
R10	Has_value Arg1:T23 Arg2:T24	
T25	Qualifier 559 578	post bronchodilator
R11	Has_qualifier Arg1:T23 Arg2:T25	
T26	Temporal 559 578	post bronchodilator
T27	Drug 564 578	bronchodilator
R12	Has_temporal Arg1:T25 Arg2:T26	
T28	Measurement 600 604	FEV1
T29	Value 605 629	< 80% of predicted value
T30	Qualifier 630 649	post-bronchodilator
T31	Temporal 630 649	post-bronchodilator
T32	Drug 635 649	bronchodilator
T33	Reference_point 564 578	bronchodilator
R13	Has_index Arg1:T26 Arg2:T33	
R14	AND Arg1:T33 Arg2:T27	
T34	Reference_point 635 649	bronchodilator
R15	AND Arg1:T34 Arg2:T32	
R16	Has_index Arg1:T31 Arg2:T34	
R17	Has_temporal Arg1:T30 Arg2:T31	
R19	Has_value Arg1:T28 Arg2:T29	
R18	Has_qualifier Arg1:T28 Arg2:T30	
T35	Multiplier 662 674	at least two
T36	Qualifier 675 683	moderate
T37	Qualifier 687 693	severe
*	OR T37 T36
T38	Condition 694 707	exacerbations
T39	Scope 675 693	moderate or severe
R20	Has_scope Arg1:T38 Arg2:T39	
T40	Observation 722 741	change in treatment
T41	Qualifier 713 741	required change in treatment
R21	Has_context Arg1:T41 Arg2:T40	
R22	Has_multiplier Arg1:T38 Arg2:T35	
T42	Drug 743 754	antibiotics
T43	Drug 756 773	systemic steroids
T44	Procedure 775 790	hospitalization
T45	Qualifier 756 764	systemic
R23	Has_qualifier Arg1:T43 Arg2:T45	
T46	Temporal 792 840	in the last 18 months prior to date of screening
T47	Reference_point 823 840	date of screening
R24	Has_index Arg1:T46 Arg2:T47	
T48	Multiplier 848 860	at least one
T49	Temporal 880 924	within the last 12 months prior to screening
T50	Reference_point 915 924	screening
R25	Has_index Arg1:T49 Arg2:T50	
R26	Has_temporal Arg1:T48 Arg2:T49	
*	OR T44 T43 T42
T51	Scope 743 790	antibiotics, systemic steroids, hospitalization
T52	Procedure 732 741	treatment
R27	AND Arg1:T40 Arg2:T52	
R28	Subsumes Arg1:T52 Arg2:T51	
R29	Has_qualifier Arg1:T38 Arg2:T41	
R30	Has_temporal Arg1:T40 Arg2:T46	
R31	Has_multiplier Arg1:T41 Arg2:T48	
T53	Observation 994 1021	self-administer inhaled AAT
T54	Observation 938 980	comply with completion of electronic diary
T55	Post-eligibility 927 981	Ability to comply with completion of electronic diary.
T56	Post-eligibility 983 1022	Ability to self-administer inhaled AAT.
T57	Post-eligibility 1024 1258	No significant abnormalities in serum hematology, serum chemistry and serum inflammatory / immunogenic markers according to the Principal Investigator's judgment, taking into considerations the potential effects of the AAT deficiency.
T58	Subjective_judgement 1024 1258	No significant abnormalities in serum hematology, serum chemistry and serum inflammatory / immunogenic markers according to the Principal Investigator's judgment, taking into considerations the potential effects of the AAT deficiency.
T59	Post-eligibility 1260 1426	No significant abnormalities in urinalysis according to the Principal Investigator's judgment, taking into considerations the potential effects of the AAT deficiency.
T60	Subjective_judgement 1260 1426	No significant abnormalities in urinalysis according to the Principal Investigator's judgment, taking into considerations the potential effects of the AAT deficiency.
T61	Procedure 1460 1463	ECG
T62	Condition 1443 1463	abnormalities in ECG
T63	Qualifier 1431 1442	significant
T64	Negation 1428 1430	No
R33	Has_qualifier Arg1:T62 Arg2:T63	
R32	Has_negation Arg1:T62 Arg2:T64	
R34	AND Arg1:T61 Arg2:T62	
T65	Subjective_judgement 1428 1490	No significant abnormalities in ECG per investigator judgment.
T66	Measurement 1505 1510	HBsAg
T67	Value 1492 1500	Negative
R35	Has_value Arg1:T66 Arg2:T67	
T68	Measurement 1519 1536	antibodies to HCV
T69	Measurement 1538 1543	HIV-1
R36	Has_value Arg1:T68 Arg2:T67	
R37	Has_value Arg1:T69 Arg2:T67	
T70	Condition 1546 1559	AAT deficient
T71	Condition 1584 1589	naïve
T72	Procedure 1605 1628	IV augmentation therapy
T73	Negation 1591 1604	not receiving
R38	Has_negation Arg1:T72 Arg2:T73	
R39	Subsumes Arg1:T71 Arg2:T72	
T75	Procedure 1667 1690	IV augmentation therapy
*	OR T71 T75
R40	AND Arg1:T70 Arg2:T71	
T74	Procedure 1729 1736	therapy
T76	Temporal 1737 1781	for at least 3 months prior to the screening
T77	Reference_point 1768 1781	the screening
R41	Has_index Arg1:T76 Arg2:T77	
T78	Observation 1796 1815	willing to continue
T79	Temporal 1832 1853	throughout this trial
T80	Reference_point 1843 1853	this trial
R42	Has_index Arg1:T79 Arg2:T80	
R43	Has_temporal Arg1:T78 Arg2:T79	
R44	Has_temporal Arg1:T74 Arg2:T76	
T81	Qualifier 1711 1717	stable
R45	Has_qualifier Arg1:T74 Arg2:T81	
T82	Condition 2128 2136	pregnant
T83	Negation 2124 2127	Non
T84	Condition 2142 2151	lactating
T85	Negation 2138 2141	non
T86	Person 2152 2158	female
T87	Measurement 2185 2199	pregnancy test
T88	Value 2203 2211	negative
R46	Has_value Arg1:T87 Arg2:T88	
R47	Has_negation Arg1:T82 Arg2:T83	
R48	Has_negation Arg1:T84 Arg2:T85	
T89	Device 2230 2251	contraceptive methods
T90	Subjective_judgement 2252 2287	deemed reliable by the investigator
T91	Temporal 2300 2316	at least 2 years
T92	Condition 2317 2332	post-menopausal
T93	Condition 2336 2357	surgically sterilized
T94	Procedure 2336 2346	surgically
R49	AND Arg1:T93 Arg2:T94	
*	OR T93 T92
T95	Qualifier 2252 2287	deemed reliable by the investigator
R50	Has_qualifier Arg1:T89 Arg2:T95	
R51	AND Arg1:T95 Arg2:T90	
T96	Scope 2317 2357	post-menopausal or surgically sterilized
R52	Has_temporal Arg1:T96 Arg2:T91	
*	OR T89 T96 T87
T97	Scope 2124 2158	Non-pregnant, non-lactating female
A3	Optional T97
T98	Scope 2185 2357	pregnancy test is negative and who are using contraceptive methods deemed reliable by the investigator, or who are at least 2 years post-menopausal or surgically sterilized
R53	Has_scope Arg1:T97 Arg2:T98	
